Several mechanisms have been proposed to explain steroid resistance in T-ALL including activation of AKT1, which phosphorylates serine 134 of NR3C1, thereby preventing nuclear translocation [13]. Here, NR3C1 is linked to acute lymphoblastic leukemia.